<?xml version="1.0" encoding="UTF-8"?>
<p>In humans, arthritogenic alphavirus infection typically causes a febrile illness characterized by high viremia, maculopapular skin rash, muscle pain, hallmark debilitating polyarthralgia, polyarthritis with or without effusions, and in some cases lymphadenopathy.
 <xref rid="imr12825-bib-0003" ref-type="ref">3</xref>, 
 <xref rid="imr12825-bib-0006" ref-type="ref">6</xref> The virus incubation period prior to the clinical manifestations depends on the alphavirus species. Typically, it is relatively short with an average of 7‐9 days.
 <xref rid="imr12825-bib-0002" ref-type="ref">2</xref> The disease is self‐limiting and usually resolves within 2 weeks, but chronic pathologies such as polyarthritis may develop, which could last from months to years.
 <xref rid="imr12825-bib-0007" ref-type="ref">7</xref> Neurological complications are rare, but recent reports have suggested that serious clinical forms of CHIKV disease could compromise brain tissues leading to permanent neurological damage.
 <xref rid="imr12825-bib-0008" ref-type="ref">8</xref>, 
 <xref rid="imr12825-bib-0009" ref-type="ref">9</xref>, 
 <xref rid="imr12825-bib-0010" ref-type="ref">10</xref>, 
 <xref rid="imr12825-bib-0011" ref-type="ref">11</xref>
</p>
